Biogen IDEC, Incorporated (BIIB)

SHARE
TEXT SIZE:
SHARE
Send a copy to me

Separate multiple email addresses (max 20) with commas.

0/1500
James C. Mullen , CEO/President/Director
Industry: Healthcare
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME


Overview
News
People
Financials

Company Information

James C. Mullen, CEO/President/Director

14 Cambridge Center

Cambridge, MA 02142

US Map it

Phone: (617) 679-2000

Fax: (617) 679-2617

www.biogenidec.com



Overview

A biotechnology company, which is engaged in the development, manufacturing and commercialization of therapies.

Portfolio Blogs
News From Around the Web
Blogs
powered by  inform

Employees

Number of Employees: 4,300
Revenue per Employee: $799,024

Financials

Quarterly
Annual

Income Statement 10/2008 08/2008 04/2008 02/2008
Sales 74.39 Mil. 59.73 Mil. 68.78 Mil. 158.49 Mil.
Gross Operating Profit 1.02 Bil. 933.71 Mil. 596.29 Mil. 734.81 Mil.
Operating Income before D & A (EBITDA) 516.95 Mil. 402.34 Mil. 122.23 Mil. 311.79 Mil.
Total Income Before Interest Expenses (EBIT) 321.12 Mil. 291.33 Mil. 246.37 Mil. 295.06 Mil.
Total Net Income 206.79 Mil. 206.63 Mil. 163.1 Mil. 201.15 Mil.
Basic EPS, Total 0.71 0.71 0.55 0.68
Diluted EPS, Total 0.7 0.7 0.54 0.37

BALANCE STATEMENT 10/2008 08/2008 04/2008 02/2008
Cash and Equivalents 1.01 Bil. 466.49 Mil. 688.5 Mil. 979.07 Mil.
Total Assets 2.64 Bil. 2.16 Bil. 2.14 Bil. 2.37 Bil.
Total Liabilities 985.87 Mil. 885.44 Mil. 707.17 Mil. NA
Total Capitalization 6.81 Bil. 6.56 Bil. 6.59 Bil. 5.53 Bil.

Cash Flow 10/2008 08/2008 04/2008 02/2008
Net Cash From Continuing Operations 1.16 Bil. 643.01 Mil. 366.98 Mil. NA
Net Cash From Investing Activities 99.88 Mil. 199.35 Mil. 449.58 Mil. NA
Net Cash From Financing Activities -902.83 Mil. -1.04 Bil. -787.53 Mil. NA
Net Change in Cash & Cash Equivalents 351.04 Mil. -193.17 Mil. 28.84 Mil. NA

powered by Interactive Data

Income Statement 2008 2007 2006 2005
Sales 592.69 Mil. 165.51 Mil. 273.71 Mil. 462.56 Mil.
Gross Operating Profit 2.58 Bil. 2.53 Bil. 2.15 Bil. 1.75 Bil.
Operating Income before D & A (EBITDA) 877.66 Mil. 1.12 Bil. 756.36 Mil. 482.85 Mil.
Total Income Before Interest Expenses (EBIT) 938.03 Mil. 499.8 Mil. 265.84 Mil. 82.99 Mil.
Total Net Income 638.17 Mil. 217.51 Mil. 160.71 Mil. 25.09 Mil.
Basic EPS, Total 2.02 0.64 0.48 0.07
Diluted EPS, Total 1.99 0.63 0.47 0.07

BALANCE STATEMENT 2008 2007 2006 2005
Cash and Equivalents 979.07 Mil. 661.38 Mil. 568.17 Mil. 209.45 Mil.
Total Assets 2.37 Bil. 1.71 Bil. 1.62 Bil. 1.93 Bil.
Total Liabilities NA 582.86 Mil. 583.04 Mil. 1.26 Bil.
Total Capitalization 5.53 Bil. 7.25 Bil. 6.95 Bil. 6.93 Bil.

Cash Flow 2008 2007 2006 2005
Net Cash From Continuing Operations NA 841.27 Mil. 889.5 Mil. 727.99 Mil.
Net Cash From Investing Activities NA -599.77 Mil. 417.74 Mil. -382.43 Mil.
Net Cash From Financing Activities NA -148.41 Mil. -948.52 Mil. -450.96 Mil.
Net Change in Cash & Cash Equivalents NA 93.21 Mil. 358.72 Mil. -105.4 Mil.

powered by Interactive Data







Related Companies by Market Cap
Company Name
Price
Change
Market Cap
19.59 Bil.
19.86 Bil.
4.38 Bil.
4.27 Bil.

Company Profile Change Request

The data provided in our company profiles comes from third party information providers.

Also in Portfolio.com
Most Read
Most Emailed
Recently Commented

Newsletter Sign-Up
Subscribe
Newsletter Sign-Up
Subscribe